107 filings
Page 2 of 6
15-12B
ORPHY
Orphazyme A/S
31 Mar 22
Securities registration termination
5:31pm
6-K
ORPHY
Orphazyme A/S
31 Mar 22
Current report (foreign)
3:16pm
6-K
ORPHY
Orphazyme A/S
29 Mar 22
Current report (foreign)
7:42am
EFFECT
ORPHY
Orphazyme A/S
24 Mar 22
Notice of effectiveness
12:15am
6-K
ORPHY
Orphazyme A/S
22 Mar 22
Orphazyme announces withdrawal of European Marketing Authorisation Application for arimoclomol for the treatment of Niemann-Pick disease type C
7:25am
6-K
ORPHY
Orphazyme A/S
21 Mar 22
Current report (foreign)
6:03pm
S-8 POS
ORPHY
Orphazyme A/S
21 Mar 22
Registration of securities for employees (post-effective amendment)
4:36pm
S-8 POS
ORPHY
Orphazyme A/S
21 Mar 22
Registration of securities for employees (post-effective amendment)
4:33pm
POS AM
ORPHY
Orphazyme A/S
21 Mar 22
Prospectus update (post-effective amendment)
4:27pm
25
ORPHY
Orphazyme A/S
21 Mar 22
Voluntary exchange delisting
4:23pm
6-K
ORPHY
Orphazyme A/S
18 Mar 22
Current report (foreign)
8:13am
6-K
ORPHY
Orphazyme A/S
10 Mar 22
Current report (foreign)
5:09pm
6-K
ORPHY
Orphazyme A/S
3 Mar 22
Current report (foreign)
7:43am
6-K
ORPHY
Orphazyme A/S
28 Feb 22
Current report (foreign)
6:57am
6-K
ORPHY
Orphazyme A/S
24 Feb 22
Orphazyme A/S Company announcement
6:26am
6-K
ORPHY
Orphazyme A/S
18 Feb 22
Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program
4:09pm
6-K
ORPHY
Orphazyme A/S
15 Feb 22
Current report (foreign)
3:36pm
6-K
ORPHY
Orphazyme A/S
14 Feb 22
Current report (foreign)
12:00am
6-K
ORPHY
Orphazyme A/S
11 Feb 22
Current report (foreign)
7:01am
SC 13G/A
ORPHY
Orphazyme A/S
3 Feb 22
Orphazyme A/S / LSP V Cooperatieve U.A. ownership change
4:16pm